Current filters:


8137 to 8146 of 97252 results

European approval for Mundipharma/SkyePharma's asthma drug Flutiform


After some delays, the European Commission has now adopted a legally binding decision in favor of granting…

EuropeFlutiformMundipharmaPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

AnGes deal with Mitsubishi Tanabe Pharma for Collategene in USA


AnGes MG (TYO: 4563) has concluded a basic agreement with fellow Japanese drugmaker Mitsubishi Tanabe…

AnGes MDCardio-vascularCollategeneLicensingMitsubishi TanabePharmaceutical

Sinclair IS returns Episil rights to Camurus, retaining some distribution


UK-based specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) has returned the commercial rights for Episil(…

CamurusEpisilLicensingNeurologicalPharmaceuticalSinclair IS Pharma

GSK settlement still not enough to deter Pharma, says Public Citizen


This week's announcement of the largest health fraud settlement ever reached between a pharmaceutical…

FinancialGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

News briefs: Priority review for ocriplasmin; Zonegran monotherapy in EU


Belgium-based biopharma firm ThromboGenics (Euronext Brussels: THR) says that the US Food and Drug Administration…

EisaiEuropeNeurologicalNorth AmericaocriplasminOphthalmicsPharmaceuticalRegulationThromboGenicsZonegran

Antivirals market facing generics threat, especially for HIV drugs


Generic copies of branded drugs are predicted to take over the antiviral drugs market, especially in…

Anti-viralsGenericsMarkets & MarketingPatentsPharmaceutical

Botulinum toxin a shot in the arm for preventing MS tremor


Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with multiple sclerosis…

Botulinum toxinNeurologicalPharmaceuticalResearch

Blackmores acquires FIT-BioCeuticals for A$40 million


Australia's Blackmores (ASX:BKL) says that it has agreed to acquire 100% of the issued share capital…

Asia-PacificBlackmoresFIT-BioCeuticalsMergers & AcquisitionsPharmaceutical

GlaxoSmithKline to plead guilty and pay record $3 billion to resolve US fraud allegations


UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed to plead guilty and to pay $3 billion - the largest…

FinancialGlaxoSmithKlineLegalMarkets & MarketingNorth AmericaPharmaceutical

8137 to 8146 of 97252 results

Back to top